Vanda Pharmaceuticals Inc. (VNDA)

Vanda (VNDA) Income Statement


Vanda Income Statement

Last quarter (Q2 2023), Vanda's total revenue was $46.06M, a decrease of -28.47% from the same quarter last year. In Q2, Vanda's net income was $1.52M. See Vanda’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 238.35M$ 254.38M$ 268.68M$ 248.17M$ 227.19M$ 193.12M
Cost of Revenue
$ 9.82M-$ 25.63M$ 23.36M$ 24.49M$ 20.51M
Gross Profit
$ 228.53M$ 254.38M$ 243.05M$ 224.80M$ 202.70M$ 172.61M
Operating Expense
$ 226.05M$ 248.05M$ 200.89M$ 197.56M$ 179.89M$ 150.87M
Operating Income
$ 2.48M$ 6.33M$ 42.16M$ 27.24M$ 22.81M$ 21.74M
Net Non Operating Interest Income Expense
Other Income Expense
$ -11.30M$ -4.97M$ 199.00K$ 4.42M$ 6.22M$ 3.61M
Pretax Income
$ 23.26M$ 11.30M$ 42.36M$ 31.66M$ 29.03M$ 25.35M
Tax Provision
$ 8.32M$ 5.03M$ 9.21M$ 8.32M$ -86.53M$ 138.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 14.95M$ 6.28M$ 33.15M$ 23.34M$ 115.55M$ 25.21M
Basic EPS
$ 0.26$ 0.11$ 0.60$ 0.43$ 2.17$ 0.50
Diluted EPS
$ 0.26$ 0.11$ 0.58$ 0.42$ 2.11$ 0.48
Basic Average Shares
$ 227.50M$ 56.46M$ 55.55M$ 54.43M$ 53.14M$ 50.86M
Diluted Average Shares
$ 228.89M$ 56.98M$ 56.92M$ 55.19M$ 54.85M$ 53.05M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
-----$ 0.76
Rent Expense Supplemental
Total Expenses
$ 235.87M$ 248.05M$ 226.52M$ 220.93M$ 204.38M$ 171.38M
Net Income From Continuing And Discontinued Operation
$ 14.99M$ 6.28M$ 33.15M$ 23.34M$ 115.55M$ 25.21M
Normalized Income
$ 5.32M-$ 33.15M$ 23.34M$ 115.55M$ 25.21M
Interest Expense
$ 21.70M$ 11.30M$ 42.16M$ 27.24M$ 22.81M$ 21.74M
$ 13.73M$ 14.02M$ 45.01M$ 30.10M$ 25.70M$ 24.69M
Currency in USD

Vanda Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis